Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II salvage therapy with clofarabine combination for resistant childhood leukemia
2008-004487-39Phase 2Active
- Sponsor
- Istituto Giannina Gaslini
- Start
- Mar 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of clofarabine in Acute Leukaemia, sponsored by Istituto Giannina Gaslini. Primary endpoints: Efficacy of clofarabine combination to reach complete remission, Tolerability of clofarabine combination and 1 more. Started Mar 2009; status: active.
02
Drugs
clofarabine
03
Conditions
Acute Leukaemia
Beyond the preview
Go deeper on 2008-004487-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004487-39.